We have placed cookies on your computer to help make this website better. We use a PIWIK Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by PIWIK (e.g. deny use/opt-out).

I'm ok with this

Stories | Media | Grünenthal Group

Explore our recent stories to see what drives us.

Stories By:
Public Private Partnership
MOBILISE-D – mobilisation as one core aspect of pain management
Joining forces for patient-driven R&D
Partnering to empower patients to shape medical innovation through the PARADIGM initiative.
Clinical trial transparency
Grünenthal aims to be in the top 10 for clinical trial transparency
Getting patients back to what matters most
Neosaxitoxin pushes the boundaries in post-operative pain management and addresses the opioid-crisis by providing a non-opioid alternative for patients and clinicians.
Placebo Effect and Pain
The placebo response: a hot topic for pain researchers?
Giving CRPS patients hope
Neridronate is giving hope to those affected by CRPS – one of the most painful conditions a patient can experience.
Searching for a game-changer
CaV2.2 non-opioid medicine for managing severe pain
The future of pain medicines:
The Leitmarktwettbewerb LifeSciences.NRW project “NeuRoWeg”